News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

U.S. Federal Circuit Court Affirms Judgment for Allergan Inc. (AGN) and Roche Palo Alto (RHHBF.PK) against Apotex Inc., Apotex Corp.., and Novex Pharma in Ketorolac Patent Infringement Lawsuit


4/12/2007 12:33:45 PM

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN) announced today that the United States Court of Appeals for the Federal Circuit has affirmed a favorable ruling for Allergan and Roche Palo Alto, LLC, formerly known as Syntex (U.S.A.) LLC, in a patent infringement lawsuit against Apotex, Inc., Apotex Corp., and Novex Pharma (the “Defendants”) preventing the Defendants from obtaining U.S. Food and Drug Administration approval to market a generic version of Allergan’s product ACULAR® (ketorolac tromethamine ophthalmic solution) 0.5% and enjoining the Defendants from manufacturing or selling the same.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES